Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | diacylglycerol kinase, putative | 0.0439 | 0 | 0.5 |
Plasmodium vivax | diacylglycerol kinase, putative | 0.0439 | 0 | 0.5 |
Schistosoma mansoni | integrin beta subunit | 0.0561 | 0.0113 | 0.0113 |
Mycobacterium tuberculosis | Conserved protein | 1.1276 | 1 | 1 |
Echinococcus multilocularis | sphingosine kinase 1 | 1.1276 | 1 | 1 |
Onchocerca volvulus | 0.0439 | 0 | 0.5 | |
Leishmania major | sphingosine kinase A, B, putative | 0.0439 | 0 | 0.5 |
Trypanosoma brucei | Sphingosine kinase | 0.0439 | 0 | 0.5 |
Trypanosoma brucei | diacylglycerol kinase, putative | 0.0439 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, putative | 0.0439 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase-like protein, putative | 0.0439 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, putative | 0.0439 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, zeta, iota, putative | 0.0439 | 0 | 0.5 |
Schistosoma mansoni | sphingoid long chain base kinase | 1.1276 | 1 | 1 |
Schistosoma mansoni | sphingosine kinase A B | 1.1276 | 1 | 1 |
Brugia malayi | Integrin beta pat-3 precursor | 0.0976 | 0.0495 | 1 |
Loa Loa (eye worm) | hypothetical protein | 1.1276 | 1 | 1 |
Echinococcus multilocularis | integrin beta 2 | 0.0714 | 0.0254 | 0.0254 |
Trichomonas vaginalis | bmru protein, putative | 0.0439 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase-like protein, putative | 0.0439 | 0 | 0.5 |
Plasmodium falciparum | diacylglycerol kinase, putative | 0.0439 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, epsilon, putative | 0.0439 | 0 | 0.5 |
Leishmania major | diacylglycerol kinase, putative | 0.0439 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase, putative | 0.0439 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 1.1276 | 1 | 1 |
Toxoplasma gondii | diacylglycerol kinase accessory domain (presumed) domain-containing protein | 0.0439 | 0 | 0.5 |
Trichomonas vaginalis | sphingosine kinase, putative | 0.0439 | 0 | 0.5 |
Echinococcus granulosus | integrin beta 2 | 0.0714 | 0.0254 | 0.0254 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0439 | 0 | 0.5 |
Trypanosoma cruzi | Diacylglycerol kinase catalytic domain containing protein, putative | 0.0439 | 0 | 0.5 |
Onchocerca volvulus | Ceramide kinase 1 homolog | 0.0439 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase, putative | 0.0439 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0439 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 1.1276 | 1 | 1 |
Loa Loa (eye worm) | integrin beta-2 | 0.0976 | 0.0495 | 0.0495 |
Leishmania major | hypothetical protein, conserved | 0.0439 | 0 | 0.5 |
Trichomonas vaginalis | sphingosine kinase, putative | 0.0439 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0439 | 0 | 0.5 |
Plasmodium falciparum | diacylglycerol kinase, putative | 0.0439 | 0 | 0.5 |
Trypanosoma cruzi | Sphingosine kinase | 0.0439 | 0 | 0.5 |
Toxoplasma gondii | diacylglycerol kinase catalytic domain-containing protein | 0.0439 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, zeta, iota, putative | 0.0439 | 0 | 0.5 |
Trichomonas vaginalis | bmru protein, putative | 0.0439 | 0 | 0.5 |
Plasmodium vivax | diacylglycerol kinase, putative | 0.0439 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0439 | 0 | 0.5 |
Trypanosoma brucei | Diacylglycerol kinase catalytic domain containing protein, putative | 0.0439 | 0 | 0.5 |
Leishmania major | diacylglycerol kinase-like protein | 0.0439 | 0 | 0.5 |
Trypanosoma cruzi | Sphingosine kinase | 0.0439 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.